Ledger.Open graph →

SEC Form D · filed March 1, 2022

Biolexis Therapeutics, Inc

Offering

$2.0M

Sold

$1.5M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SANDY, UT

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

David J. Taylor · Sandy, UTExec David J. Bearss · Oro Valley, AZExec Hariprasad J. Vankayalapati · Sandy, UTExec · Director Hariprasad J. Vankayalapati · Sandy, UTExec · Director David J. Taylor · Sandy, UTExec David J. Bearss · Oro Valley, AZExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗